ALKERMES | ALKS - 资产

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	资产	更改		日
AbbVie	USD 133.96B		62M	2025-12
Acadia Pharmaceuticals	USD 1.56B		233.42M	2025-12
ALKERMES	USD 2.49B		157.48M	2025-12
Amgen	USD 90.59B		445M	2025-12
Biogen	USD 29.44B		232M	2025-12
BioMarin Pharmaceutical	USD 7.59B		20.85M	2025-12
Bristol-Myers Squibb	USD 96.89B		2.21B	2025-09
Coherus Biosciences	USD 258.34M		258.18M	2025-12
Eli Lilly	USD 112.48B		2.46B	2025-12
Gilead Sciences	USD 59.02B		490M	2025-12
Heron Therapeutics	USD 255.88M		6.93M	2025-12
Ionis Pharmaceuticals	USD 3.52B		490.91M	2025-12
J&J	USD 200.89B		1.68B	2026-03
Malin Corporation	EUR 198.5M		70.1M	2024-12
Merck	USD 129.55B		12.02B	2025-09
Minerva Neurosciences	USD 97.97M		69.88M	2025-12
Nektar Therapeutics	USD 280.41M		20.94M	2025-12
Neurocrine Biosciences	USD 4.63B		365.8M	2025-12
Otsuka Holdings	JPY 4.2T		238.02B	2025-12
Ovoca Bio	EUR 1.66M		9.75M	2025-06
Pfizer	USD 208.73B		2.64B	2025-09
Regeneron Pharmaceuticals	USD 40.56B		389.3M	2025-12
Vertex Pharmaceuticals	USD 25.64B		780.7M	2025-12